About FDA

Description: Two new CERSIs have been established between the FDA and teams of leading scientists at the University of California at San Francisco (UCSF) in a joint effort with Stanford University, and Johns Hopkins University (JHU). Both partners received FDA funding through a competitive application process to establish CERSIs that will promote cross-disciplinary regulatory science training, scientific exchanges, and leading-edge research focused on FDA science priority areas. The UCSF-Stanford CERSI will bring West Coast representation to the CERSI network and enable the FDA to access UCSF’s powerhouse in quantitative sciences and in drug development whereas the Johns Hopkins CERSI will focus on three core FDA strategic priorities: clinical evaluations, social and behavioral science, and food safety. Collaborating with our academic partners is crucial to our ability to expand the FDA’s scientific foundation and infrastructure in order to deliver on the promises of using 21st century science and technology to fulfill our regulatory mission. The UCSF-Stanford CERSI will be three years long while JHU will be two years long.